TARS EBITDA Growth
Tarsus Pharmaceuticals Inc · EBITDA Growth
TARS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported56.53%period ending
TARS TTM EBITDA YoY % (-1033.00% → 56.53%)
Year-over-year change
High-resolution chart · PNG
TARS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 56.5333% | |
| 57.3918% | |
| 47.4681% | |
| 42.651% | |
| 43.6685% | |
| 34.2048% | |
| 19.1692% | |
| -21.8341% | |
| -64.2122% | |
| -130.0075% | |
| -120.9119% | |
| -68.8481% | |
| -57.5091% | |
| -41.544% | |
| -343.0238% | |
| -507.288% | |
| -1,194.7234% | |
| -213.8962% | |
| 49.9684% | |
| 38.6607% | |
| 39.1083% | |
| -238.6247% | |
| -1,032.9964% |